Charles River Laboratories International Inc. Stock Rises 5.7%, Outperforms Peers

Dow Jones
2025/12/04

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Charles River Laboratories International Inc. rose 5.7% to $184.67 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.3% to 6,849.72 and the Dow Jones Industrial Average rising 0.9% to 47,882.90.

The stock's rise snapped a three-day losing streak.

Charles River Laboratories International Inc. closed 8.9% short of its 52-week high of $202.72, which the company achieved on December 10th.

The stock outperformed some of its peers, as Labcorp Holdings Inc. fell 0.1% to $265.76, Alnylam Pharmaceuticals Inc. rose 1.8% to $473.29, and Bio-Techne Corp. rose 1.38% to $63.82.

Trading volume totaled 770,440, compared to the 50-day average of 1.0 million.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

December 03, 2025 16:34 ET (21:34 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10